XPNPEP2 and Alzheimer disease: PTEN is mislocalized and accumulated in the NFTs of AD patients leading to the inhibition of PI3 K and PP2 A. Intense immunolabeling was found in the large neurons, such as pyramidal cells, although reduced expression and redistribution of PTEN in the remaining neurons in AD.